A detailed history of Hanlon Investment Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Hanlon Investment Management, Inc. holds 7,089 shares of PFE stock, worth $188,283. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,089
Holding current value
$188,283
% of portfolio
0.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$27.7 - $31.39 $196,365 - $222,523
7,089 New
7,089 $205,000
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $188,660 - $216,642
7,287 New
7,287 $202,000
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $168,503 - $219,962
4,036 New
4,036 $0
Q2 2022

Jul 27, 2022

BUY
$46.53 - $55.17 $182,723 - $216,652
3,927 New
3,927 $206,000
Q1 2022

Apr 26, 2022

SELL
$45.75 - $56.69 $155,824 - $193,086
-3,406 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$41.32 - $61.25 $140,735 - $208,617
3,406 New
3,406 $201,000
Q3 2021

Nov 19, 2021

SELL
$39.25 - $50.42 $306,110 - $393,225
-7,799 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $88,374 - $100,113
-2,461 Reduced 23.99%
7,799 $305,000
Q1 2021

Apr 16, 2021

BUY
$33.49 - $37.77 $1,507 - $1,699
45 Added 0.44%
10,260 $372,000
Q4 2020

Feb 09, 2021

SELL
$33.47 - $42.56 $6,024 - $7,660
-180 Reduced 1.73%
10,215 $376,000
Q3 2020

Nov 17, 2020

BUY
$31.75 - $37.25 $10,160 - $11,920
320 Added 3.18%
10,395 $381,000
Q2 2020

Jul 21, 2020

BUY
$30.12 - $36.54 $1,144 - $1,388
38 Added 0.38%
10,075 $329,000
Q1 2020

Apr 22, 2020

SELL
$27.03 - $38.62 $2,892 - $4,132
-107 Reduced 1.05%
10,037 $328,000
Q4 2019

Jan 16, 2020

BUY
$32.92 - $37.36 $1,119 - $1,270
34 Added 0.34%
10,144 $397,000
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $326,102 - $422,858
-10,037 Reduced 49.82%
10,110 $363,000
Q2 2019

Aug 15, 2019

BUY
$36.98 - $41.52 $24,258 - $27,237
656 Added 3.37%
20,147 $873,000
Q1 2019

Jul 02, 2019

BUY
$37.5 - $41.2 $730,912 - $803,029
19,491 New
19,491 $828,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hanlon Investment Management, Inc. Portfolio

Follow Hanlon Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanlon Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hanlon Investment Management, Inc. with notifications on news.